Prevention of Diet-Induced Metabolic Dysregulation, Inflammation, and Atherosclerosis in LDLR −/− Mice by Treatment With the ATP-Citrate Lyase Inhibitor Bempec AcidHighlights

Arteriosclerosis, Thrombosis, and Vascular Biology - United States
doi 10.1161/atvbaha.116.308963

Related search